Cytokinetics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $16,927 | $463 | $249 | $835 |
Gross Profit | -76,702 | -84,149 | -2,157 | -1,496 |
EBITDA | -125,043 | -138,247 | -116,613 | -115,991 |
EBIT | -127,426 | -140,658 | -119,019 | -118,322 |
Net Income | -150,020 | -160,545 | -143,318 | -135,643 |
Net Change In Cash | 16,927 | 463 | 249 | 835 |
Free Cash Flow | -66,860 | -103,955 | -101,228 | -127,753 |
Cash | 94,857 | 46,888 | 190,517 | 120,351 |
Basic Shares | 111,979 | 117,685 | 109,240 | 101,924 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $18,474 | $7,530 | $94,588 | $70,428 |
Gross Profit | 18,474 | -322,593 | -146,225 | -89,510 |
EBITDA | -493,483 | -456,684 | -329,400 | -176,345 |
EBIT | -503,014 | -468,576 | -337,799 | -185,982 |
Net Income | -589,526 | -526,244 | -402,552 | -242,370 |
Net Change In Cash | 18,474 | 7,530 | 94,588 | 70,428 |
Cost of Revenue | -45,484 | 29,681 | ||
Free Cash Flow | -399,796 | -415,749 | -310,851 | -191,394 |
Cash | 94,857 | 113,024 | 65,582 | 112,666 |
Basic Shares | 111,979 | 96,524 | 89,825 | 76,886 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$1.26 |
2024-09-30 | -$1.36 |
2024-06-30 | -$1.31 |
2024-03-31 | -$1.33 |
